Developing story — details emerging. Check the source link for the latest updates.
Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.
The investigation into the Democrat predates the current Trump administration. But the timing of the indictment before the midterms has raised eyebrows.
Developing story — details emerging. Check the source link for the latest updates.
Developing story — details emerging. Check the source link for the latest updates.
Monroe Capital CEO Ted Koenig says daily marks on illiquid private-credit assets create an illusion of precision, not accuracy. He discusses the deal slowdown, pressure on private-equity exits and why he's cautious about data centers and GPU lending.